imec.xpand
Venture capitalPre-Seed–Seed · 11 people tracked
Investment thesis
imec.xpand targets entrepreneurs driving nanoelectronics-based innovation through a global early-stage investment platform. The firm leverages exclusive access to imec's research infrastructure, including state-of-the-art cleanroom facilities worth over €2 billion, extensive networks, and multi-disciplinary expertise to identify disruptive technologies and accelerate portfolio company growth. As one of Europe's few truly international early-stage VCs, it combines deep technical resources with global co-investor and industry partnerships.
Source: firm website, verified Jul 21, 2026.
Team · 11 people
from the firm's websiteA repeat entrepreneur experienced in converting technology into viable business models. He possesses deep knowledge of imec and assists in evaluating the uniqueness, technological feasibility, and scalability of ventures.
A venture capital professional with extensive experience on the business side of VC investing. He provides portfolio companies access to a broad network of venture capitalists, corporate partners, and entrepreneurs.
A bio-engineer with a PhD in medical sciences who has launched innovative products addressing user pain points. He actively supports portfolio companies in achieving commercial success.
An electrical engineer and IC designer investing in deeptech opportunities. He specializes in supporting companies pursuing ambitious projects in semiconductor and photonics technology.
A venture capital investor with a strong background in technology R&D who helps portfolio companies develop and execute growth strategies from early-stage concepts to global technology leadership.
An investor with over 20 years of venture capital experience in health-tech. He brings expertise from successfully exiting early-stage investments and mentors companies through growth phases.
An engineer with a multidisciplinary background in electrical and biomedical engineering. He leverages an international network to help deeptech startups and founders advance emerging technologies.
A former CEO of an early-stage photonics startup who thinks like an entrepreneur and is passionate about solving real-world problems through technological innovation.
A professional with communications and business expertise focused on the intersection of research and entrepreneurship. She is motivated by the societal impact created through innovation valorization.
A chemist with expertise in energy and novel memory devices who identifies driven founders tackling significant technical bottlenecks and challenging conventional business models.
A marketing and communications professional who helps entrepreneurs develop compelling narratives and supports companies throughout their journey from early-stage startup to global business.
What they invest in
from 1 of 33 portfolio companiesAI & Machine Learning ×1Biotech ×1Deep Tech ×1
Investments · 33 tracked
founders shown can be your intro pathZafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities. The platform leverages AI and high-resolution data to compress timelines in drug development.
AI & Machine LearningBiotechDeep Tech
Swamy VijayanYi ZhangVikas GoelJustin Briggs
Frequently asked questions
- What stage does imec.xpand invest at?
- imec.xpand invests at the Pre-Seed, Seed stages.
- What sectors does imec.xpand focus on?
- imec.xpand focuses on Deep Tech, Semiconductors.
Images
Similar investors
Cottonwood Technology Fund is an early-stage deep tech venture capital fund focused on patent-driven companies in hard science sectors including photonics, quantum, advanced materials, and climatetech, with offices in the Southwest US and Northern Europe.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Tennr streamlines patient flow in healthcare by automating referral management, insurance verification, clinical context aggregation, and appointment scheduling. The platform processes referrals and intake documentation for approximately 10% of Americans annually.
An AI-first venture capital firm founded in 2016 that invests across the full AI stack, including next-generation compute chips, AI infrastructure, robotics, and agentic AI solutions. The team originated from Stanford and leverages deep domain expertise and access to frontier research talent.
An early-stage venture capital firm investing in technology founders building solutions across multiple sectors.